Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 1 trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Phase 3 Country / region: Netherlands Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20023
20032
20041
20061
20081
20091
20101
20111
20123
20131
20141
20154
20161
20171
20212
20221
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting4
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S11
Sanofi4
Eli Lilly and Company3
Boehringer Ingelheim2
AstraZeneca1
Chromaderm, Inc.1
Diamyd Medical AB1
Diamyd Therapeutics AB1
Ixaka Ltd1
Lexicon Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 130
Diabetes Mellitus12
Diabetes Mellitus, Type 24
Autoimmune Diseases1
Cardiovascular Diseases1
Chronic Limb-Threatening Ischemia1
Diabetic Neuropathies1
Hypoglycemia1
Immune System Diseases1
Metabolic Diseases1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.